Insider Transactions in Q1 2024 at Arcellx, Inc. (ACLX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,450
-14.58%
|
$376,050
$69.37 P/Share
|
|
Mar 26
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,450
+27.47%
|
$32,700
$6.28 P/Share
|
|
Mar 22
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
41,365
-31.24%
|
$2,895,550
$70.83 P/Share
|
|
Mar 22
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+28.45%
|
$120,000
$6.28 P/Share
|
|
Mar 21
2024
|
Jill Carroll |
SELL
Open market or private sale
|
Indirect |
504,263
-25.42%
|
$35,298,410
$70.55 P/Share
|
|
Mar 18
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,825
-23.74%
|
$470,925
$69.38 P/Share
|
|
Mar 15
2024
|
Olivia C Ware |
SELL
Open market or private sale
|
Direct |
9,000
-58.04%
|
$630,000
$70.26 P/Share
|
|
Mar 15
2024
|
Olivia C Ware |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+50.0%
|
$63,000
$7.61 P/Share
|
|
Feb 12
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,967
-8.92%
|
$189,888
$64.46 P/Share
|
|
Feb 12
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
11,169
-10.79%
|
$714,816
$64.46 P/Share
|
|
Feb 09
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,688
-9.98%
|
$232,344
$63.4 P/Share
|
|
Feb 09
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
13,886
-11.83%
|
$874,818
$63.4 P/Share
|
|
Feb 08
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,456
-8.55%
|
$214,272
$62.29 P/Share
|
|
Feb 08
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
13,010
-9.98%
|
$806,620
$62.29 P/Share
|
|
Feb 07
2024
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
70,211
+35.0%
|
-
|
|
Feb 07
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,555
+35.82%
|
-
|
|
Jan 04
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,598
-29.85%
|
$417,890
$55.27 P/Share
|
|
Jan 04
2024
|
Rami Elghandour |
SELL
Open market or private sale
|
Direct |
29,073
-32.57%
|
$1,599,015
$55.27 P/Share
|
|
Jan 04
2024
|
Michelle Gilson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,514
-34.3%
|
$468,270
$55.27 P/Share
|
|
Jan 03
2024
|
Rami Elghandour |
BUY
Exercise of conversion of derivative security
|
Direct |
53,097
+37.3%
|
-
|
|
Jan 03
2024
|
Christopher Heery CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,519
+39.35%
|
-
|